Concepedia

Xing Yu

XY

Statistics

Publications

22

Citations

3.1K

H-Index

16

Active since

1997

Affiliations

Ionis Pharmaceuticals (United States)(Current)

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine

University of Illinois Urbana-Champaign

Howard Hughes Medical Institute

Yale University

Xing Yu is an author at Ionis Pharmaceuticals (United States) specializing in life sciences, metabolism, and biochemistry.

ORCID

Publications per year

1997–2024

22

Publications

22

Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis

Kanji Yamaguchi, Liu Yang, Shannon J. McCall et al. · Hepatology · 2007 · 1K citations · Full text

, , +17

Fibroblast Growth Factor 19 Increases Metabolic Rate and Reverses Dietary and Leptin-Deficient Diabetes

Ling Fu, Linu M. John, Sean H. Adams et al. · Endocrinology · 2004 · 566 citations

, , +12

Suppression of Diacylglycerol Acyltransferase-2 (DGAT2), but Not DGAT1, with Antisense Oligonucleotides Reverses Diet-induced Hepatic Steatosis and Insulin Resistance

Cheol Soo Choi, David B. Savage, Ameya Kulkarni et al. · Journal of Biological Chemistry · 2007 · 375 citations · Full text

, , +15

Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice†

Xing Yu, Susan F. Murray, Sanjay K. Pandey et al. · Hepatology · 2005 · 303 citations · Full text

, , +17

SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats

Derek M. Erion, Shin Yonemitsu, Yongzhan Nie et al. · Proceedings of the National Academy of Sciences · 2009 · 179 citations · Full text

, , +17

1–5 of 22